Literature DB >> 12504931

Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.

N J Sebire1, R A Fisher, M Foskett, H Rees, M J Seckl, E S Newlands.   

Abstract

OBJECTIVE: To determine pregnancy outcome, including the rate of repeat molar pregnancy, following histologically confirmed complete or partial hydatidiform mole.
DESIGN: Retrospective review of a large supraregional database of registrations for gestational trophoblastic disease.
SETTING: Supraregional Trophoblastic Disease Unit, London. SAMPLE: Women with pregnancies affected by complete or partial hydatidiform mole registered between 1992 and 1998.
METHODS: All patients with a diagnosis of histologically confirmed complete or partial hydatidiform mole were identified and data on subsequent pregnancies compared between groups using comparison of proportion test. MAIN OUTCOME MEASURES: Pregnancy outcome by partial or complete mole subtype, with particular regard to risk of subsequent molar pregnancy.
RESULTS: Of 2578 complete moles, the subsequent pregnancy was affected by hydatidiform mole in 27 (1.9%) cases, including 22 (81%) complete moles and 5 (19%) partial moles. Of 2627 partial moles, the subsequent pregnancy was also molar in 25 (1.7%) cases, including 17 (68%) partial moles and 8 (32%) complete moles. Overall recurrence risk for molar pregnancy was 1.8% (1 in 55), or a 20-fold increase compared with the background risk. Of 27 cases with repeat complete moles, three had further complete moles, suggesting the recurrence risk following two previous complete moles is approximately 10%. There were no other significant differences in pregnancy outcome between cases with previous complete or partial hydatidiform mole and that expected in an unselected obstetric population.
CONCLUSIONS: Women having a pregnancy affected by a histologically confirmed complete or partial hydatidiform mole may be counselled that the risk of repeat mole in a subsequent pregnancy is about 1 in 60 and if this were to occur, the majority of cases will be of the same type of mole as the preceding pregnancy. However, >98% of women who become pregnant following a molar conception will not have a further hydatidiform mole and these pregnancies are at no increased risk of other obstetric complications.

Entities:  

Mesh:

Year:  2003        PMID: 12504931

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  36 in total

1.  Abnormal villous morphology associated with triple trisomy of paternal origin.

Authors:  Alexis Norris-Kirby; Jill M Hagenkord; Malti P Kshirsagar; Brigitte M Ronnett; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2010-04-22       Impact factor: 5.568

Review 2.  The hydatidiform mole.

Authors:  Jean-Jacques Candelier
Journal:  Cell Adh Migr       Date:  2015-09-30       Impact factor: 3.405

Review 3.  Molecular genetic studies of complete hydatidiform moles.

Authors:  Louise Carey; Benjamin M Nash; Dale C Wright
Journal:  Transl Pediatr       Date:  2015-04

4.  A strong founder effect for two NLRP7 mutations in the Indian population: an intriguing observation.

Authors:  R Slim; R Bagga; W Chebaro; R Srinivasan; N Agarwal
Journal:  Clin Genet       Date:  2009-07-24       Impact factor: 4.438

5.  Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay.

Authors:  Kathleen M Murphy; Thomas G McConnell; Michael J Hafez; Russell Vang; Brigitte M Ronnett
Journal:  J Mol Diagn       Date:  2009-10-08       Impact factor: 5.568

6.  Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization.

Authors:  Sarah Chiang; Ladan Fazlollahi; Anhthu Nguyen; Rebecca A Betensky; Drucilla J Roberts; A John Iafrate
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

7.  Live euploid birth and complete hydatid mole, followed by partial hydatid mole after ICSI.

Authors:  Ming-Tzeung Chung; Chii-Ruey Tzeng; Ching-Hui Chen; Cindy Chan; Yi-En Chang; Yi-Hua Wu; Chi-Huang Chen
Journal:  J Assist Reprod Genet       Date:  2018-06-02       Impact factor: 3.412

8.  Surveillance without chemotherapy in a woman with recurrent molar pregnancy.

Authors:  Rashmi Bagga; Sujata Siwatch; Radhika Srinivasan; Lakhbir Kaur Dhaliwal
Journal:  BMJ Case Rep       Date:  2013-02-20

9.  The genomic architecture of NLRP7 is Alu rich and predisposes to disease-associated large deletions.

Authors:  Ramesh Reddy; Ngoc M P Nguyen; Guillaume Sarrabay; Maryam Rezaei; Mayra C G Rivas; Aysenur Kavasoglu; Hakan Berkil; Alaa Elshafey; Ebtesam Abdalla; Kristin P Nunez; Hélène Dreyfus; Merviel Philippe; Zahra Hadipour; Asude Durmaz; Erin E Eaton; Brittany Schubert; Volkan Ulker; Fatemeh Hadipour; Fatemeh Ahmadpour; Isabelle Touitou; Majid Fardaei; Rima Slim
Journal:  Eur J Hum Genet       Date:  2016-03-09       Impact factor: 4.246

10.  Clinical presentation and treatment outcome of molar pregnancy: Ten years experience at a Tertiary Care Hospital in Dammam, Saudi Arabia.

Authors:  Ayman A Al-Talib
Journal:  J Family Community Med       Date:  2016 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.